A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B-Reference-Cited by-同舟云学术

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

Published:2010-03 Issue:3 Volume:52 Page:330-339
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Tan Anthony T.,Koh Sarene,Goh Winnie,Zhe Heng Yee,Gehring Adam J.,Lim Seng Gee,Bertoletti Antonio

Publisher

Elsevier BV

Subject

Hepatology

Reference38 articles.

1. Hepatitis B virus Infection;Dienstag;N Engl J Med,2008

2. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease;Perrillo;Gastroenterology,2001

3. Serology of acute exacerbation in chronic hepatitis B virus infection;Maruyama;Gastroenterology,1993

4. Acute exacerbation of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion;Tsai;J Clin Invest,1992

5. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy;Webster;J Virol,2004

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum IP-10 increase correlated with PEG-IFNα response in nucleot(s)ide analogs-treated patients with chronic hepatitis B;iLIVER;2024-09

2. Cell‐type‐specific expression analysis of liver transcriptomics with clinical parameters to decipher the cause of intrahepatic inflammation in chronic hepatitis B;iMeta;2024-07-04

3. The immune response in chronic HBV infection;Journal of Viral Hepatitis;2024-06-06

4. Clinical outcomes of cessation of nucleoside/nucleotide analogues in Chinese patients with HBeAg-negative chronic hepatitis B;iLIVER;2024-06

5. Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy;The Journal of Immunology;2024-01-31